Before enrollment, all involved patients provided written informed consent to participate in the study and have their data and pictures anonymously used for publication
The latest trials demonstrated weight loss of up to nearly 23 percent of starting body weight - positioning retatrutide as perhaps the most powerful weight loss drug yet developed for adults with heart disease or type 2 diabetes
According to Novo Nordisk and the FDA website, Novo Nordisk is the only company in the U.S
Gaining this knowledge could greatly improve the health and well-being of millions of postmenopausal women, said Maria Daniela Hurtado Andrade, M.D., Ph.D., assistant professor of medicine and consultant for the Division of Endocrinology at the Mayo Clinic
The challenge is that we don't have so much data in type 2 diabetes and gestational diabetes
Generic manufacturers with clean cost structures and direct-to-patient capabilities would gain share in a transparent market